From: Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling
Feature | p (FET) | nGS | pGS | nGB | pGB | OR |
---|---|---|---|---|---|---|
Necrosis reported? | 0.62 | 2/48 | 4.2% | 31/1181 | 2.6% | 1.6 |
Tumor was recurrent or residual? | 0.49 | 7/48 | 15% | 132/1181 | 2.6% | 1.6 |
Oligodendroglial features? | 0.63 | 0/48 | 0% | 18/1181 | 1.5% | 0 |
Intratumoral hemorrhage? | 1 | 0/48 | 0% | 7/1181 | 0.6% | 0 |
Features of giant cell GB? | 1 | 0/48 | 0% | 7/1181 | 0.6% | 0 |
Features of epithelioid GB? | 1 | 0/48 | 0% | 6/1181 | 0.5% | 0 |
Gemistocytic? | 1 | 0/48 | 0% | 4/1181 | 0.3% | 0 |
Features of small-cell GB? | 1 | 0/48 | 0% | 6/1181 | 0.5% | 0 |
Treatment effect/ radiation necrosis? | 0.68 | 0/48 | 0% | 14/1181 | 1.2% | 0 |
Fibrillary? | 1 | 0/48 | 0 | 1/1181 | 0.09% | 0 |